BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36000446)

  • 1. Single-cell RNA-sequencing dissects cellular heterogeneity and identifies two tumor-suppressing immune cell subclusters in HPV-related cervical adenosquamous carcinoma.
    Li X; Zhang M; Lei T; Zou W; Huang R; Wang F; Huang Q; Wang C; Liu C
    J Med Virol; 2022 Dec; 94(12):6047-6059. PubMed ID: 36000446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptomics dissects epithelial heterogeneity in HPV
    Wang C; Li L; Wang F; Li X; Sun J; Li X; Lei T; Huang Q; Zhang G; Wang H; Li D; Jia J; Li C; Geng F; Yue J; Liu C
    J Med Virol; 2023 Feb; 95(2):e28480. PubMed ID: 36609919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
    Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
    Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing.
    Li C; Liu D; Zhao Y; Ding Y; Hua K
    J Med Virol; 2023 Jun; 95(6):e28857. PubMed ID: 37287196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
    Liu Y; Lu Z; Xu R; Ke Y
    Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Int J Gynecol Cancer; 2001; 11(1):39-48. PubMed ID: 11285032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR).
    Yamakawa Y; Forslund O; Teshima H; Hasumi K; Kitagawa T; Hansson BG
    Gynecol Oncol; 1994 May; 53(2):190-5. PubMed ID: 8188078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
    Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
    Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus-18.
    Fujiwara H; Mitchell MF; Arseneau J; Hale RJ; Wright TC
    Cancer; 1995 Nov; 76(9):1591-600. PubMed ID: 8635063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV subtypes and immunological parameters of cervical cancer in Iceland during two time periods, 1958-1960 and 1995-1996.
    Mikaelsdottir EK; Benediktsdottir KR; Olafsdottir K; Arnadottir T; Ragnarsson GB; Olafsson K; Sigurdsson K; Kristjansdottir GS; Imsland AK; Ogmundsdottir HM; Rafnar T
    Gynecol Oncol; 2003 Apr; 89(1):22-30. PubMed ID: 12694650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix.
    Teshima H; Beaudenon S; Koi S; Katase K; Hasumi K; Masubuchi K; Orth G
    Arch Gynecol Obstet; 1997; 259(4):169-77. PubMed ID: 9271836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallels and divergence in head and neck and cervical cancer.
    Sethi N
    BJOG; 2015 Jan; 122(1):128. PubMed ID: 25545903
    [No Abstract]   [Full Text] [Related]  

  • 16. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization.
    Tase T; Okagaki T; Clark BA; Manias DA; Ostrow RS; Twiggs LB; Faras AJ
    Cancer Res; 1988 Feb; 48(4):993-8. PubMed ID: 2827890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6/E7-based polymerase chain reaction.
    Sakamoto J; Saito M; Zhang S; Takakura M; Takagi H; Sasagawa T
    PLoS One; 2022; 17(4):e0265996. PubMed ID: 35381047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
    Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
    Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus DNA in cervical carcinoma--correlation with clinical data and influence on prognosis.
    Ikenberg H; Sauerbrei W; Schottmüller U; Spitz C; Pfleiderer A
    Int J Cancer; 1994 Nov; 59(3):322-6. PubMed ID: 7927936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
    Zhao C; Li Z; Austin RM
    Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.